Faint hope for Alder as Teva bucks dismal migraine trend

Faint hope for Alder as Teva bucks dismal migraine trend

Source: 
EP Vantage
snippet: 

Alder hopes soon to launch its migraine drug eptinezumab, and will nervously have been watching the first full quarter’s sales of three similarly acting drugs.